Nanomedicine News

RSS

NanoGap Sensor Device for Early Detection of Bladder and Kidney Cancer

A new mobile device that allows bladder and kidney cancer to be detected at an early stage. This is being worked on by Wilfred van der Wiel, professor of nanoelectronics at the University of Twente MESA+ research institute. Thanks to this method, it is possible to read from DNA cells whether their carrier has bladder or kidney cancer.

16 Feb 2015

Baxter Provides Update on Gene Therapy Program for Hemophilia B at EAHAD Annual Congress

Baxter International Inc. today provided an update on its gene therapy program, including progress on the Phase I/II open-label clinical trial assessing the safety and optimal dosing level of BAX 335, an investigational factor IX (FIX) gene therapy treatment for hemophilia B, during a sponsored symposium at the 8th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD) in Helsinki, Finland.

13 Feb 2015

Novavax Commences Enrollment in Phase 1 Clinical Trial of Ebola GP Vaccine

Novavax, Inc., a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today announced that enrollment has begun in a Phase 1 clinical trial of its Ebola virus glycoprotein (GP) recombinant nanoparticle vaccine candidate adjuvanted with Matrix-M™ (Ebola GP Vaccine) in healthy subjects.

From Novavax Inc. 13 Feb 2015

Researchers Demonstrate Biomedical Use of Gold Nanotubes in Mouse Model of Human Cancer

Scientists have shown that gold nanotubes have many applications in fighting cancer: internal nanoprobes for high-resolution imaging; drug delivery vehicles; and agents for destroying cancer cells.

13 Feb 2015

Nanostructured Porous Silicon for Chemotherapy Drug Delivery Behaves Differently in Cancerous Tumors

A team of Israeli and American researchers have found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.

13 Feb 2015

FDA Grants NanoSmart Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin

NanoSmart® Pharmaceuticals, Inc., a private pharmaceutical company developing nanoparticle drug delivery platforms, has received Orphan Drug Designation from the Food and Drug Administration (FDA) for one of its lead candidates, antinuclear antibody (ANA) conjugated liposomal doxorubicin. The drug product is initially intended to treat Ewing's sarcoma, a rare type of cancer that develops in or around children's bones, with potential expansion into other indications.

12 Feb 2015

Heating Targeted Nano-Sized Drug Parcels Improves Delivery to Tumour Cells

Manchester scientists have found that gentle heating of targeted nano-sized drug parcels more effectively in deliver them to tumour cells – resulting in an improvement in survival rates.

12 Feb 2015

New Report on Global Nanobiotechnology Market

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Nanobiotechnology Applications, Markets and Companies" to their offering.

From Research and Markets 12 Feb 2015

BIONOVA Offers Treatment for Blemish Control

Blemish skin is a common problem often confused with Acne. The cause of skin blemishes is the local imbalance of skin metabolism while Acne is a skin decease caused by hormonal imbalances, overactive sebum production (skin oil) and the existence of a specific bacterial flora. If Acne skin is always Oily, Blemish skin can be Normal, Oily and Dry type.

12 Feb 2015

Panacea, Accelovance Enter Agreement to Advance Novel Nanoparticle-Based Therapeutic Cancer Vaccine

Panacea Pharmaceuticals, Inc. and Accelovance Inc. today announced the establishment of a clinical development services agreement to develop and advance Panacea's oncology immunotherapy pipeline.

12 Feb 2015

Nanomedicine News

NanoGap Sensor Device for Early Detection of Bladder and Kidney Cancer

Baxter Provides Update on Gene Therapy Program for Hemophilia B at EAHAD Annual Congress

Novavax Commences Enrollment in Phase 1 Clinical Trial of Ebola GP Vaccine

Researchers Demonstrate Biomedical Use of Gold Nanotubes in Mouse Model of Human Cancer

Nanostructured Porous Silicon for Chemotherapy Drug Delivery Behaves Differently in Cancerous Tumors

FDA Grants NanoSmart Orphan Drug Designation for ANA-Conjugated Liposomal Doxorubicin

Heating Targeted Nano-Sized Drug Parcels Improves Delivery to Tumour Cells

New Report on Global Nanobiotechnology Market

BIONOVA Offers Treatment for Blemish Control

Panacea, Accelovance Enter Agreement to Advance Novel Nanoparticle-Based Therapeutic Cancer Vaccine

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable Carbon Nanomaterial Gii Set to Transform Energy Storage in Internet of Things Devices

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials